Cargando…

Comparative Effectiveness of Radiotherapy versus Focal Laser Ablation in Patients with Low and Intermediate Risk Localized Prostate Cancer

At present, focal laser ablation (FLA) as a new PCa local treatment has attracted attention. We aim at comparing the survival outcomes between radiotherapy (RT) and FLA to reveal whether FLA can be used as an alternative to RT for patients with low and intermediate-risk localized PCa.We conducted an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xianghong, Jin, Kun, Qiu, Shi, Jin, Di, Liao, Xinyang, Tu, Xiang, Zheng, Xiaonan, Li, Jiakun, Yang, Lu, Wei, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272634/ https://www.ncbi.nlm.nih.gov/pubmed/32499484 http://dx.doi.org/10.1038/s41598-020-65863-8

Ejemplares similares

Comparing effectiveness of radical prostatectomy versus external beam radiotherapy in patients with locally advanced prostate cancer: A population-based analysis
por: Zhou, Xianghong, et al.
Publicado: (2020)

Cryotherapy shows no inferiority compared with radical Prostatectomy for low-risk and intermediate-risk localized Prostate Cancer: a real-world study from the SEER database
por: Jin, Kun, et al.
Publicado: (2020)

How to choose proper local treatment in men aged ≥75 years with cT2 localized prostate cancer?
por: Jin, Kun, et al.
Publicado: (2019)

Development of prognostic signature based on immune-related genes in muscle-invasive bladder cancer: bioinformatics analysis of TCGA database
por: Jin, Kun, et al.
Publicado: (2021)

The comparison of survival between active surveillance or watchful waiting and focal laser ablation in patients with low-risk prostate cancer
por: Li, Jia-Kun, et al.
Publicado: (2022)

The accumulation of metabolic syndrome components is associated with higher risk of positive surgical margin among patients with localized prostate cancer after radical prostatectomy
por: Zheng, Xiaonan, et al.
Publicado: (2019)

Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study
por: Zhou, Xianghong, et al.
Publicado: (2021)

Focal Laser Ablation of Prostate Cancer: Definition, Needs, and Future
por: Colin, Pierre, et al.
Publicado: (2012)

Significance of tertiary Gleason pattern 5 in patients with Gleason score 7 after radical prostatectomy: a retrospective cohort study
por: Li, Jiakun, et al.
Publicado: (2019)

Focal Laser Ablation of Prostate Cancer: Numerical Simulation of Temperature and Damage Distribution
por: Marqa, Mohamad-Feras, et al.
Publicado: (2011)

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
por: Nicholls, Luke, et al.
Publicado: (2020)

Transperineal laser ablation (TPLA) with ultrasound/MRI fusion guidance in the treatment of localized radiotherapy-resistant prostate cancer
por: Manenti, Guglielmo, et al.
Publicado: (2023)

Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
por: Guo, Wei, et al.
Publicado: (2019)

Ablation energies for focal treatment of prostate cancer
por: Lodeizen, Olivia, et al.
Publicado: (2018)

Oncological outcomes of patients with ductal adenocarcinoma of the prostate receiving radical prostatectomy or radiotherapy
por: Liu, Mengzhu, et al.
Publicado: (2021)

Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project
por: van Luijtelaar, A., et al.
Publicado: (2019)

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives
por: Lo Greco, Maria Chiara, et al.
Publicado: (2023)

MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging
por: Bomers, Joyce G. R., et al.
Publicado: (2016)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

Feasibility and safety of targeted focal microwave ablation of the index tumor in patients with low to intermediate risk prostate cancer: Results of the FOSTINE trial
por: Barry Delongchamps, Nicolas, et al.
Publicado: (2021)

Single-Center Experience of Focal Thermo-Ablative Therapy After Pelvic Radiotherapy for In-Field Prostate Cancer Oligo-Recurrence
por: Giraud, Nicolas, et al.
Publicado: (2021)

Active surveillance and focal therapy for low-intermediate risk prostate cancer
por: Klotz, Laurence
Publicado: (2015)

Tumor‐associated macrophages promote bladder tumor growth through PI3K/AKT signal induced by collagen
por: Qiu, Shi, et al.
Publicado: (2019)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

Focal cryosurgical ablation of the prostate: a single institute’s perspective
por: Hale, Zachary, et al.
Publicado: (2013)

Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results
por: Aluwini, Shafak, et al.
Publicado: (2013)

Focal salvage therapy for local prostate cancer recurrences after primary radiotherapy: a comprehensive review
por: Duijzentkunst, D. A. Smit, et al.
Publicado: (2016)

Stereotactic prostate focal reirradiation therapy for local recurrence: preliminary results of Hartmann Oncology Radiotherapy Group
por: Scher, Nathaniel, et al.
Publicado: (2019)

Stereotactic ablative radiotherapy for oligometastatic prostate cancer
por: Gallizia, Elena, et al.
Publicado: (2022)

Comparative evaluation of hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate and high risk prostate cancer
por: Soni, Abhishek, et al.
Publicado: (2022)

Commentary on: “Focal cryosurgical ablation of the prostate: A single institute’s perspective”
por: Metwalli, Adam R, et al.
Publicado: (2013)

Efficacy and Toxicity of Whole Pelvic Radiotherapy Versus Prostate-Only Radiotherapy in Localized Prostate Cancer: A Systematic Review and Meta-Analysis
por: Wang, Shilin, et al.
Publicado: (2022)

Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial
por: Scheltema, Matthijs J. V., et al.
Publicado: (2016)

Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma
por: Zhou, Xianghong, et al.
Publicado: (2020)

Stereotactic ablative body radiotherapy in patients with prostate cancer
por: Loblaw, Andrew, et al.
Publicado: (2018)

Future perspective of focal therapy for localized prostate cancer
por: O'Connor, Luke P., et al.
Publicado: (2021)

Focal therapy for localized prostate cancer – Current status
por: Atluri, Shrikanth, et al.
Publicado: (2022)

Associations between the dietary inflammatory index and urinary incontinence among women younger than 65 years
por: Zhang, Shiyu, et al.
Publicado: (2021)

Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
por: Kim, Hun Jung, et al.
Publicado: (2016)

Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?
por: Amit, Uri, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_87l8oh53jc3ho2im5kg8pb4nep